Shannon James Samuel

Track

Insider profile

Performance

Overall performance
2.2
Performance over holding periods
2.2
30 days 90 days 120 days
Average return -2% 8.2% 15.1%
Success rate 3% 68% 82%
Transactions
6 50% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Shannon James Samuel's trades of Xilio Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
91.30
Quantity 7,232 -100.0%
Value US$660,261
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-30 2026-03-26
B Purchase
73,192 -24.1%
219.85
US$2,742,174 		73,192 -24.1% 219.85 US$2,742,174
2025-06-18 2025-06-17
B Purchase
42,383 +43.9%
199.53
US$4,534,218 		42,383 +43.9% 199.53 US$4,534,218
2025-06-18 2025-06-16
B Purchase
15,023 +14.3%
125.63
US$2,589,042 		15,023 +14.3% 125.63 US$2,589,042
2021-03-03 2021-03-01
S Sale
7,232 -100.0%
91.30
US$660,261 		7,232 -100.0% 91.30 US$660,261
2019-09-13 2019-09-13
S Sale
9,500 -100.0%
26.19
US$248,805 		9,500 -100.0% 26.19 US$248,805
2019-09-13 2019-09-12
S Sale
15,500 -100.0%
26.59
US$412,131 		15,500 -100.0% 26.59 US$412,131